Open- | Close- |
Vol / Avg.0 / 89.525K | Mkt Cap181.852M |
Day Range- - - | 52 Wk Range1.990 - 6.290 |
Harvard Bioscience Stock (NASDAQ: HBIO) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 89.525K | Mkt Cap181.852M |
Day Range- - - | 52 Wk Range1.990 - 6.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.040 | 0.010 | -0.0300 | ||||
REV | 28.020M | 25.363M | -2.657M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.040 | -0.0100 | ||||
REV | 29.500M | 28.759M | -741.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-22 | Benchmark | Bruce Jackson | Reiterates | Speculative BuySpeculative Buy | Maintains | - | 7.00 |
2023-04-26 | Benchmark | Bruce Jackson | Maintains | Buy | Raises | 4.00 | 7.00 |
2023-04-26 | Keybanc | Paul Knight | Maintains | Overweight | Raises | 5.00 | 7.00 |
2023-03-10 | Benchmark | Kenneth Bruce | Reiterates | Buy | Maintains | - | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HBIO | Harvard Bioscience | 0% | 181.9M |
CDXS | Codexis | -0.42% | 164.1M |
BLFS | BioLife Solns | 0% | 557.2M |
CDT | Conduit Pharmaceuticals | -5.98% | 320.4M |
SLGC | SomaLogic | -0.71% | 526.6M |
You can purchase shares of Harvard Bioscience (NASDAQ: HBIO) through any online brokerage.
Other companies in Harvard Bioscience’s space includes: Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Conduit Pharmaceuticals (NASDAQ:CDT), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Harvard Bioscience (NASDAQ: HBIO) was reported by Benchmark on Thursday, June 22, 2023. The analyst firm set a price target for 7.00 expecting HBIO to rise to within 12 months (a possible 64.32% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Harvard Bioscience (NASDAQ: HBIO) is $4.26 last updated November 30, 2023 at 9:00 PM UTC.
There is no dividend information for Harvard Bioscience.
Harvard Bioscience’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Harvard Bioscience.
Harvard Bioscience is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.